Search Result "Complement dependent cytotoxicity/CDC"
Role of Complement-dependent Cytotoxicity Crossmatch and HLA Typingin Solid Organ Transplant
Journal: Reviews on Recent Clinical Trials
Volume: 19 Issue: 1 Year: 2024 Page: 34-52
Author(s):
Inhibition of Membrane Complement Inhibitor Expression (CD46, CD55, CD59) by siRNA Sensitizes Tumor Cells to Complement Attack
Ebook: Advances in Cancer Drug Targets
Volume: 3 Year: 2016
Author(s): Srinivas Mamidi,Simon Höne,Nicolas Geis,Stefanie Zell,Renate Rutz,Wenhan Li,Thomas Giese,Stefan Schultz,Michael Kirschfink
Doi: 10.2174/9781681082332116030004
Inhibition of Membrane Complement Inhibitor Expression (CD46, CD55, CD59) by siRNA Sensitizes Tumor Cells to Complement Attack In Vitro
Journal: Current Cancer Drug Targets
Volume: 10 Issue: 8 Year: 2010 Page: 922-931
Author(s): N. Geis, S. Zell, R. Rutz, W. Li, T. Giese, S. Mamidi, S. Schultz, M. Kirschfink
Pharmacokinetic Properties of Rituximab
Journal: Reviews on Recent Clinical Trials
Volume: 3 Issue: 1 Year: 2008 Page: 22-30
Author(s): Jose Rodriguez, Antonio Gutierrez
P-Selectin Glycoprotein Ligand-1 as a Potential Target for Humoral Immunotherapy of Multiple Myeloma (Supplementry Material)
Journal: Current Cancer Drug Targets
Volume: 9 Issue: 5 Year: 2009 Page: 617-625
Author(s): C. Tripodo, A. M. Florena, P. Macor, A. Di Bernardo, R. Porcasi, C. Guarnotta, S. Ingrao, M. Zerilli, E. Secco, M. Todaro, F. Tedesco, V. Franco
Current Technological Development of Antibody Therapeutics
Journal: Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry
Volume: 11 Issue: 1 Year: 2011 Page: 21-32
Author(s): Ayami Yamaguchi, Katsuaki Usami, Kazuhiro Masuda
Removal of the Tag from His-tagged ILYd4, a Human CD59 Inhibitor, Significantly Improves its Physical Properties and its Activity
Journal: Current Pharmaceutical Design
Volume: 18 Issue: 27 Year: 2012 Page: 4187-4196
Author(s): Lin Wu,Sanbao Su,Fengming Liu,Tao Xu,Xiaoxiao Wang,Yan Huang,Xinlu Sun,Xiaowen Ge,Ting Chen,Huixia Liu,Chun Wang,Michael Chorev,Ting Xu,Xuebin Qin
Insights into the Role of Fc Gamma Receptors (FcγRs) Genetic Variations in Monoclonal Antibody-Based Anti-Cancer Therapy
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 5 Issue: 3 Year: 2010 Page: 197-204
Author(s): Fabio Concetti, Valerio Napolioni
Engineering Antibodies for Therapy
Journal: Current Pharmaceutical Biotechnology
Volume: 3 Issue: 3 Year: 2002 Page: 237-256
Author(s): Leonard G. Presta
Monoclonal Antibodies in Clinical Oncology
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 8 Issue: 5 Year: 2008 Page: 523-532
Author(s): S. Dalle, C. Thieblemont, L. Thomas, C. Dumontet